Ee Ming Wong

Summary

Affiliation: Peter MacCallum Cancer Centre
Country: Australia

Publications

  1. pmc Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry
    Letitia D Smith
    Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Melbourne, Victoria 3010, Australia
    Breast Cancer Res 13:R14. 2011
  2. pmc BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype
    Cameron Snell
    Molecular Pathology Research and Development Laboratory, Department of Pathology, Peter MacCallum Cancer Centre, Locked Bag 1, A Beckett St, Melbourne, Victoria 8006, Australia
    Breast Cancer Res 10:R12. 2008
  3. doi Assessing gene-specific methylation using HRM-based analysis
    Ee Ming Wong
    Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia
    Methods Mol Biol 687:207-17. 2011
  4. pmc The use of DNA from archival dried blood spots with the Infinium HumanMethylation450 array
    Jihoon E Joo
    Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Victoria, 3010, Australia
    BMC Biotechnol 13:23. 2013
  5. pmc Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer
    Ee Ming Wong
    Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria 8006, Australia
    Cancer Prev Res (Phila) 4:23-33. 2011

Collaborators

Detail Information

Publications5

  1. pmc Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry
    Letitia D Smith
    Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Melbourne, Victoria 3010, Australia
    Breast Cancer Res 13:R14. 2011
    ..We sought to test the value of selecting women for BRCA1 mutation testing on the basis of family history and/or breast tumour morphology criteria as well as the value of testing for large genomic alterations in BRCA1...
  2. pmc BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype
    Cameron Snell
    Molecular Pathology Research and Development Laboratory, Department of Pathology, Peter MacCallum Cancer Centre, Locked Bag 1, A Beckett St, Melbourne, Victoria 8006, Australia
    Breast Cancer Res 10:R12. 2008
    ..We hypothesised that inactivation of BRCA1 by promoter methylation could occur as a germline or an early somatic event that predisposes to breast cancer with the phenotype normally associated with BRCA1 germline mutation...
  3. doi Assessing gene-specific methylation using HRM-based analysis
    Ee Ming Wong
    Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia
    Methods Mol Biol 687:207-17. 2011
    ....
  4. pmc The use of DNA from archival dried blood spots with the Infinium HumanMethylation450 array
    Jihoon E Joo
    Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Victoria, 3010, Australia
    BMC Biotechnol 13:23. 2013
    ....
  5. pmc Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer
    Ee Ming Wong
    Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria 8006, Australia
    Cancer Prev Res (Phila) 4:23-33. 2011
    ..This raises the possibility of chemoprevention or other intervention to diminish the risk of developing breast cancer in these women...